19-55378186-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000291934.4(TMEM190):c.517G>A(p.Glu173Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000968 in 1,549,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000291934.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM190 | NM_139172.3 | c.517G>A | p.Glu173Lys | missense_variant | 5/5 | ENST00000291934.4 | NP_631911.1 | |
TMEM190 | XM_017026331.2 | c.391G>A | p.Glu131Lys | missense_variant | 4/4 | XP_016881820.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM190 | ENST00000291934.4 | c.517G>A | p.Glu173Lys | missense_variant | 5/5 | 1 | NM_139172.3 | ENSP00000291934.3 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151702Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000402 AC: 8AN: 199060Hom.: 0 AF XY: 0.0000378 AC XY: 4AN XY: 105886
GnomAD4 exome AF: 0.0000100 AC: 14AN: 1397858Hom.: 0 Cov.: 34 AF XY: 0.00000728 AC XY: 5AN XY: 687230
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151820Hom.: 0 Cov.: 29 AF XY: 0.0000135 AC XY: 1AN XY: 74164
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2024 | The c.517G>A (p.E173K) alteration is located in exon 5 (coding exon 5) of the TMEM190 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the glutamic acid (E) at amino acid position 173 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at